Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
for
Breast Cancer, Early-stage Breast Cancer
Location: Washington D.C. DC
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: Female
Age: 18+
Code: NCT06536881
Recruiting
Pre-operative Hypofractionated Proton Therapy
for
Soft Tissue Sarcoma
Location: Washington D.C. DC
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18+
Code: NCT05917301
Recruiting
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Washington D.C. DC, Alexandria VA, Fairfax VA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06500481
Phase 3, Recruiting
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
for
Breast Cancer, Insomnia, Weight Gain
Location: Washington D.C. DC, Baltimore MD, Lutherville MD
Sponsor: Johns Hopkins University
Sex: Female
Age: 18+
Code: NCT05780814
Recruiting
Proton Radiation Therapy Registry
for
Cancer, Therapy-Related
Location: Washington D.C. DC, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18 - 70+
Code: NCT04376229
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
for
Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme,
Location: Washington D.C. DC, Fairfax VA, New York NY,
Sponsor: Tango Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06810544
Phase 1, Phase 2, Recruiting
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
for
Bladder Cancer
Location: Washington D.C. DC, Baltimore MD
Sponsor: Johns Hopkins University
Sex: Male
Age: 18+
Code: NCT05792722
Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Washington D.C. DC, Baltimore MD, Elkton MD, Newark DE,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase 3, Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07421700
Phase 1, Phase 2, Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
for
Bladder Cancer
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07419295
Phase 3, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
for
Advanced Renal Cell Carcinoma (RCC)
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07293351
Phase 1, Phase 2, Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for
Urothelial Cancer
Location: Washington D.C. DC, Baltimore MD, Charlottesville VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07106762
Phase 2, Phase 3, Recruiting
Pediatric Radiation Therapy Registry
for
Sarcoma, Pediatric Brain Tumors
Location: Washington D.C. DC, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 0 - 26
Code: NCT07129317
Recruiting
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Washington D.C. DC, Baltimore MD, Frederick MD,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07000084
Phase 3, Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Washington D.C. DC, Harrisburg PA, Sewell NJ,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase 3, Recruiting
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Washington D.C. DC, Bethesda MD, Baltimore MD, York PA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase 3, Recruiting
Blue Light Cystoscopy With Cysview® Registry
for
Bladder Cancer
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: Photocure
Sex: All
Age: 18+
Code: NCT02660645
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Washington D.C. DC, Baltimore MD, Frederick MD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase 3, Recruiting
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
for
Bladder Cancer
Location: Washington D.C. DC, Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT06525571
Phase 3, Recruiting
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
for
Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer,
Location: Washington D.C. DC, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins